Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2021 Apr 15;17(4):e1009366. doi: 10.1371/journal.pgen.1009366

Genetic analysis of the septal peptidoglycan synthase FtsWI complex supports a conserved activation mechanism for SEDS-bPBP complexes

Ying Li 1, Han Gong 1, Rui Zhan 1, Shushan Ouyang 1, Kyung-Tae Park 2, Joe Lutkenhaus 2,*, Shishen Du 1,*
Editor: Daniel B Kearns3
PMCID: PMC8078798  PMID: 33857142

Abstract

SEDS family peptidoglycan (PG) glycosyltransferases, RodA and FtsW, require their cognate transpeptidases PBP2 and FtsI (class B penicillin binding proteins) to synthesize PG along the cell cylinder and at the septum, respectively. The activities of these SEDS-bPBPs complexes are tightly regulated to ensure proper cell elongation and division. In Escherichia coli FtsN switches FtsA and FtsQLB to the active forms that synergize to stimulate FtsWI, but the exact mechanism is not well understood. Previously, we isolated an activation mutation in ftsW (M269I) that allows cell division with reduced FtsN function. To try to understand the basis for activation we isolated additional substitutions at this position and found that only the original substitution produced an active mutant whereas drastic changes resulted in an inactive mutant. In another approach we isolated suppressors of an inactive FtsL mutant and obtained FtsWE289G and FtsIK211I and found they bypassed FtsN. Epistatic analysis of these mutations and others confirmed that the FtsN-triggered activation signal goes from FtsQLB to FtsI to FtsW. Mapping these mutations, as well as others affecting the activity of FtsWI, on the RodA-PBP2 structure revealed they are located at the interaction interface between the extracellular loop 4 (ECL4) of FtsW and the pedestal domain of FtsI (PBP3). This supports a model in which the interaction between the ECL4 of SEDS proteins and the pedestal domain of their cognate bPBPs plays a critical role in the activation mechanism.

Author summary

Bacterial cell division requires the synthesis of septal peptidoglycan by the widely conserved SEDS-bPBP protein complex FtsWI, but how the complex is activated during cell division is still poorly understood. Previous studies suggested that FtsN initiates a signaling cascade in the periplasm to activate FtsWI. Here we isolated and characterized activated FtsW and FtsI mutants and confirmed that the signaling cascade for FtsW activation goes from FtsN to FtsQLB to FtsI and then to FtsW. The residues corresponding to mutations affecting FtsWI activation are clustered to a small region of the interaction interface between the pedestal domain of FtsI and the extracellular loop 4 of FtsW, suggesting that this interaction mediates activation of FtsW. This is strikingly similar to the proposed activation mechanism for the RodA-PBP2 complex, another SEDS-bPBP complex required for cell elongation. Thus, the two homologous SEDS-bPBP complexes are activated similarly by completely unrelated activators that modulate the interaction interface between the SEDS proteins and the bPBPs.

Introduction

The bacterial divisome is a multi-protein complex that synthesizes septal peptidoglycan during cell division in most walled bacteria [1,2]. For decades, the class A penicillin binding protein PBP1b (contains both glycosyltransferase and transpeptidase activity) in E. coli was thought to be the primary septal PG synthase [2]. However, recent studies indicate that FtsW is the essential septal PG glycosyltransferase which functions along with its cognate transpeptidase FtsI (PBP3) [3,4], a class B penicillin binding protein. PBP1b contributes to septal PG synthesis, but it is not essential since cells divide relatively normally in its absence [410]. FtsW is a member of the SEDS (shape, elongation, division and sporulation) family and is widely conserved in bacteria having a cell wall [11,12]. It contains 10 transmembrane segments and forms a complex with FtsI to synthesize septal PG [3,13]. Another SEDS-bPBP complex, formed by RodA and PBP2, synthesizes PG during cell elongation in many rod-shaped bacteria [12,14,15]. Although the divisome and elongasome each contain a SEDS-bPBP pair connected to an actin-like protein (FtsA and MreB, respectively), there are many additional components involved in regulation of these two systems (FtsQLBN vs MreCD/RodZ). Moreover, these regulators are completely unrelated. Elucidating how these disparate regulators activate these homologous complexes to synthesize PG is critical for understanding cell elongation and division.

An in vitro PG polymerization assay showed that PBP2/FtsI is necessary for the PG glycosyltransferase activity of RodA/FtsW [3,15,16], however, the mechanism by which PBP2/FtsI stimulates RodA/FtsW is not fully understood. A structure of the RodA-PBP2 complex from Thermus thermophilus revealed that there are two interaction interfaces between RodA and PBP2 (Fig 1A) [16]. One occurs in the plane of the membrane, between the single transmembrane segment of PBP2 and transmembrane segments 8 and 9 of RodA, and is important for complex formation [16]. Another occurs between the periplasmic pedestal domain of PBP2 and extracellular loop 4 (ECL4) of RodA [16]. A negative-stain electron microscopy analysis of the TtRodA-PBP2 complex suggests that this second interaction interface is transient and flexible, with very few specific interactions [16]. Nonetheless, disruption of this interaction abolished PBP2’s ability to stimulate RodA in vitro [16]. Moreover, some mutations within the ECL4 of RodA or the pedestal domain of PBP2 activate the elongasome/Rod complex in vivo [15,17]. Thus, a model emerging from these studies is that the pedestal domain of PBP2 acts as a central allosteric hub to regulate the activity of RodA through ECL4 [16]. However, ECL4 is not completely resolved in the structure of the RodA-PBP2 complex (Fig 1A, dash line) and additional evidence is required to confirm this model as well as to unravel the mechanistic details [16]. Moreover, whether this mechanism applies to FtsWI is not clear since the transmembrane segment of FtsI seems to be sufficient for FtsW activity in the in vitro PG polymerization assay [3].

Fig 1. Structure of a SEDS-bPBP protein complex and a model for FtsN-induced activation of FtsWI.

Fig 1

(A) Structure of T. thermophilus RodA-PBP2 (PDB ID#: 6P5L) and the location of the corresponding residues in FtsW and FtsI analyzed in this study. TtRodA is colored green and TtPBP2 is colored cyan, the unstructured region in ECL4 of TtRodA is colored orange. The residues are numbered according to E. coli FtsW and the catalytic residues of TtRodA and TtPBP2 are colored red. Residues altered by mutations studied here are indicated and colored orange. (B) The signal transduction pathway leading to the activation of FtsWI. FtsN switches FtsA and FtsQLB to the ON conformations via its cytoplasmic domain (Cyto) and its E domain (E), respectively. In the cytoplasm, the activation signal in FtsA is transmitted to FtsW and this is regulated by the ATPase activity of FtsEX via an interaction between FtsX and FtsA. In the periplasm, the action of the E domain of FtsN likely causes a conformational change of the FtsQLB complex at the CCD domain of FtsB and FtsL, resulting in the AWI domain (Activation of FtsWI) of FtsL becoming available to interact with FtsI. These signals synergize to activate FtsW.

Although FtsI is sufficient for the PG glycosyltranferase activity of FtsW in vitro [3], this appears to be a basal activity and another layer of regulation exists in vivo. This layer includes FtsA, FtsEX, FtsQLB, and FtsN (Fig 1B) with FtsN arriving last and triggering FtsWI activity [1825]. FtsN is a bitopic membrane protein with a short N-terminal cytoplasmic domain (FtsNcyto), a transmembrane segment, followed by an essential domain (FtsNE) and a SPOR domain in the periplasm [26]. In the current model, FtsNcyto interacts with FtsA in the cytoplasm and synergizes with the FtsNE domain in the periplasm to switch FtsA and FtsQLB to the ON states which derepress or activate the enzymatic activity of FtsWI (Fig 1B) [1,18,27].

This regulatory model is based on the isolation of ‘activation’ (superfission) mutations in ftsA, ftsB and ftsL which lessen or bypass the requirement for FtsN [18], presumably because they mimic FtsN action. The mutations in ftsB and ftsL cluster in a small region of the coiled coil domain of FtsB and FtsL termed CCD (Constriction Control Domain) [18]. A recent study found that P. aeruginosa FtsQLB, or just FtsLB, activates the PG polymerization activity of FtsWI, suggesting that FtsQLB is an activator of FtsWI and not a repressor [21]. However, FtsN did not stimulate the in vitro system, suggesting the isolated complex is already in an activated state [21]. In support of this model, FtsL mutants were isolated that still form a complex with FtsWI but are defective for cell division in vivo and fail to stimulate FtsWI in vitro [21]. Another study isolated similar variants of FtsL in E. coli and found that these mutations defined a motif in FtsL named AWI (Activating FtsWI) that is critical for activation of septal PG synthesis [22]. Further characterization of these FtsL mutants suggested a model in which the AWI domain of FtsL is likely to be exposed by FtsN action to act on FtsI to stimulate the PG polymerization activity of FtsW [22]. However, biochemical evidence for the interaction is still missing.

FtsEX has a complex role in the regulation of septal PG synthesis. It interacts with FtsA to promote the recruitment of downstream proteins but blocks septal PG synthesis if it cannot hydrolyze ATP [20,23]. Consistent with this, mutations in ftsA that disrupt this interaction alleviate the inhibition caused by an FtsEX ATPase mutant, provided that ftsA carries another mutation that bypasses the role of FtsEX in divisome assembly [20]. Mutations in the CCD domain of ftsL or ftsB that ‘activate’ the divisome in the periplasm (require less FtsN) also confer resistance to the division inhibitory activity of the FtsEX ATPase mutant which blocks the cytoplasmic signal from FtsN [20]. Interestingly, an FtsW mutant (FtsWM269I), isolated as a suppressor of the FtsEX ATPase mutant, is less dependent upon FtsN [20]. The mutation is located in the ELC4 of FtsW, potentially mimicking the FtsL-FtsI interaction and switching FtsW to an active conformation. To learn more about the activation mechanism of FtsWI, we further characterized ftsWM269I and isolated additional active ftsW and ftsI mutations in this study. Our results confirm that the signaling cascade for FtsW activation follows the order of FtsN>FtsQLB>FtsI>FtsW and supports a model in which FtsI/PBP2 activates FtsW/RodA via an interaction between their pedestal domain and the ECL4 of FtsW/RodA. This model also explains why in some bacteria FtsI is essential even though its transpeptidase activity is dispensable.

Results

Overexpression of FtsWM269I bypasses FtsN for division

Previously, we showed that FtsWM269I reduces the dependency on FtsN [20], however, it was not clear whether it can completely bypass FtsN. To check this, the growth and morphology of cells carrying either wild type ftsW or ftsWM269I on the chromosome were monitored following depletion of FtsN. The FtsN depletion strain contained a plasmid which expresses FtsN constitutively but is temperature sensitive for replication so that at 42°C the plasmid is unable to replicate and FtsN is gradually depleted. As shown in S1A Fig, the strain expressing FtsWM269I grew at 42°C whereas the strain expressing FtsW had greater than a 1000-fold plating deficiency. In liquid culture, cells with ftsW were filamentous 4 hours after the shift to 42°C. In contrast, cells expressing FtsWM269I had a normal cell size at this time, however, by 8 hours they stopped dividing and became filamentous indicating ftsN was not bypassed (S1B Fig). Consistent with this, P1 transduction of the ftsN::kan allele into a strain carrying ftsWM269I yielded colonies of varying sizes but the transductants were unable to grow when restreaked (S1C Fig). These results indicate that FtsWM269I is more efficient than FtsW for division and that a chromosomal copy of ftsWM269I almost, but not completely, bypasses FtsN.

Some activating mutations are able to bypass ftsN completely when overexpressed. One example is FtsAE124A, which was originally reported to bypass FtsN [28], however, subsequent work found that it had to be overexpressed [26]. To see if overexpression of FtsWM269I bypassed ftsN, we introduced plasmids expressing either FtsW or FtsWM269I under the control of an IPTG-inducible promoter into W3110 as well as a derivative carrying ftsWM269I on the chromosome, and then tried to knock out ftsN by P1 transduction. For a control we used a plasmid that expresses FtsN under an IPTG-inducible promoter. As shown in S2 Fig, ftsN::kan transductants were readily obtained in the presence or absence of IPTG when the control plasmid expressing ftsN was present (basal expression of ftsN from the plasmid is sufficient for complementation). As expected, ftsN::kan could not be transduced into W3110 or the strain with ftsWM269I on the chromosome when they contained a plasmid expressing ftsW. However, transductants were readily obtained with both the wild type and the FtsWM269I mutant strains when ftsWM269I was on the plasmid and induced with 60 μM IPTG (S2 Fig). These transductants grew well when restreaked in the presence of IPTG but poorly in its absence (Fig 2A). In liquid culture, cells became filamentous if FtsWM269I was not induced, whereas cells overexpressing FtsWM269I continued to divide, although these cells were longer than wild type cells (Fig 2B). These results demonstrate that overexpression of ftsWM269I can bypass FtsN.

Fig 2. Overexpression of FtsWM269I bypasses FtsN.

Fig 2

(A) IPTG-dependent growth of ftsN::kan transductants from S2 Fig. A single transductant of each strain was restreaked on LB plates with ampicillin, kanamycin, 1 mM sodium citrate and with or without 60 μM IPTG. Plates were incubated at 37°C overnight and photographed. (B) Morphology of WT and FtsWM269I cells with or without FtsN. Cells from an overnight culture of SD534 [W3110, ftsN::kan ftsWM269I/pSEB429-M269I (pDSW208, P204::ftsWM2690I)] were collected by centrifugation and washed twice with LB to remove IPTG and resuspended in the same volume of LB. The culture was diluted 1:100 and split in half, one with IPTG and one without IPTG and grown at 37°C. The control cultures (W3110 and SD488 [W3110, leu::Tn10 ftsWM269I]) were diluted 1:100 in fresh LB medium with antibiotics and grown at 37°C. Samples were taken for photography 2.5 hours after removal of IPTG. The scale bar is 5 μm.

Mutations at the M269 position can activate or inactivate FtsW

The above results demonstrate that FtsWM269I is an activated mutant which can bypass FtsN provided it is overexpressed, but how it works is not clear. Alignment of FtsW and its paralog RodA from diverse bacterial species revealed that M269 is not very conserved, but in most cases the position contains a hydrophobic amino acid (S3 Fig). Interestingly, the neighboring residue A270 is highly conserved and an A246T mutation in Caulobacter crescentus FtsW (corresponding to A270 of E. coli FtsW) produces a hyperactive division phenotype [29,30]. Also, mutation of the corresponding residue in E. coli RodA (A234T) bypasses its regulators (RodZ, MreC and MreD) in the elongasome complex [15,17]. In the recently reported TtRodA-PBP2 structure [16], the residues corresponding to M269 and A270 are located in ECL4 of TtRodA and are close to the tip of the pedestal domain of TtPBP2 (Fig 1A), which is believed to function in the allosteric activation of TtRodA. These observations suggest that the M269-A270 region of FtsW and the corresponding region of RodA play an important role in regulating their activities and further characterization of this region may provide insight into the activation mechanism of this protein family.

Since the M269I mutation is a subtle change, we tested whether other changes (M269A, M269V, M269F, M269K and M269E) would result in stronger variants that rescue the growth of an ftsN depletion strain without overexpression. If M269I disrupted an interaction to produce an active mutant, a more drastic change should be more disruptive leading to an even more active mutant. As shown in Fig 3A, substitutions that replaced M269 with hydrophobic residues supported the growth of an FtsW depletion strain about as well as the WT. However, they could not rescue the growth of the FtsN depletion strain even when overexpressed, indicating they were not activated mutants (Fig 3B). Removing the side chain of M269 (M269A) resulted in a partially functional protein that had to be overexpressed to complement whereas changing it to charged amino acids (M269K or M269E) resulted in non-functional proteins (Fig 3A). Not surprisingly, these mutants were also unable to rescue the growth of the FtsN depletion strain. These results suggest that a bulky hydrophobic residue at 269 is very important for the normal function of FtsW and M269I is a unique substitution that leads to an active FtsW. Also, introducing a charged amino acid results in an inactive protein. We also tested the A270T mutation (corresponding to the CcFtsWA246T and EcRodAA234T) to see if it was an active mutant. FtsWA270T, however, had a slightly reduced function since a higher inducer concentration was required for complementation (Fig 4A). Western blot of GFP fusion of FtsWM269K and FtsWA270T using anti-GFP antibody showed that they were expressed at the same level as wild type FtsW (Fig 4B), indicating that it was unlikely because they were unstable.

Fig 3. FtsWM269I is a unique substitution that suppresses an FtsN depletion strain.

Fig 3

(A) Complementation test of FtsW mutants. Plasmid pDSW208, pSEB429 or its derivatives carrying ftsW mutations were transformed into strain SD237 [W3110, leu::Tn10, ftsW::kan/pDSW406 (pBAD33, PBAD::ftsW)] on LB plates with ampicillin, kanamycin, chloramphenicol and 0.2% arabinose. The next day, a single transformant of each resulting strain was resuspended in 1 ml of LB medium, serially diluted. 3 μl of each dilution was spot on LB plates with antibiotics, with or without 0.2% arabinose and increasing concentrations of IPTG. Plates were incubated at 37°C overnight and photographed. (B) Spot test of the ability of FtsW mutants to rescue the growth of an FtsN depletion strain. Colonies of strain SD264 [W3110, ftsN::kan/pBL154 (pSC101ts, Psyn::ftsN, spc)] harboring pDSW208 or pSEB429 expressing FtsW variants were resuspended in 1 ml of LB medium and serially diluted. 3 μl of each dilution was spotted on LB plates with antibiotics with or without IPTG. Plates were incubated at 30°C for 24 hours or at 42°C overnight and photographed.

Fig 4. Analysis of FtsW mutants.

Fig 4

(A) Complementation test of FtsW mutants. Plasmid pDSW208, pSEB429 or its derivatives carrying ftsW mutations were transformed into strain SD237 [W3110, leu::Tn10, ftsW::kan/pDSW406 (pBAD33, PBAD::ftsW) on LB plates with ampicillin, kanamycin, chloramphenicol and 0.2% arabinose. The spot test was performed as Fig 3A. (B) Western blot to test the stability of FtsW mutants. Details about the blot is described in Materials and Methods.

Inactive FtsW mutants localize to division site and recruit downstream proteins

Since FtsWM269K and FtsWA270T did not complement, we tested whether they localized to the Z ring using a depletion strain in which FtsW was supplied from a plasmid under the control of an arabinose inducible promoter and FtsW-GFP fusions were expressed from an IPTG-inducible promoter on a compatible plasmid. As shown in Fig 5A, both FtsW-GFP and FtsWA270T-GFP localized to the division site and were able to support division in the absence of arabinose. Note that the level of FtsWA270T-GFP expressed from this plasmid is sufficient to overcome the mutant’s defect. Although FtsWM269K-GFP localized to potential division sites, it did not support division. These results indicate that FtsWM269K, and probably FtsWA270T, do not have a problem in localizing to the Z ring.

Fig 5. FtsWM269K and FtsWA270T localize to the division site and recruit FtsI.

Fig 5

(A) Localization of FtsW mutants. Localization of the FtsW mutants was assessed in the FtsW depletion strain SD237 [W3110, leu::Tn10 ftsW::kan/pDSW406 (PBAD::ftsW)] using plasmid pSD347 (P206::ftsW-l60-gfp) and derivatives carrying ftsW mutations. After removal of arabinose, IPTG was added to the culture to induce the fusion protein and 4 hours post induction cells were immobilized on 2% agarose pad for photographing. (B) Localization of FtsI. Overnight cultures of SD288 [W3110, ftsW::kan gfp-ftsI/pSD257 (pSC101ts, ftsW)] carrying plasmid pBAD33 or pDSW406 (pBAD33, PBAD::ftsW) or its derivatives grown at 30°C were diluted 1:100 in fresh LB medium with antibiotics and grown at 30°C for 2 h. The cultures were then diluted 1:10 in fresh LB medium with antibiotics, 0.2% arabinose and 10 μM IPTG and grown at 37°C for 4 hours. Cells were immobilized on 2% agarose pads for photography. The scale bar is 5 μm.

Previous studies have shown that recruitment of FtsI is due to its TM domain and flanking residues interacting with FtsW [31,32]. Since M269 and A270 are in close proximity to the interaction interface between the TM domain of FtsW and FtsI, we tested whether FtsWM269K and FtsWA270T affected the recruitment of FtsI. As expected, GFP-FtsI no longer localized to potential division sites in filaments following FtsW depletion, and adding back FtsW or FtsWA270T restored cell division and GFP-FtsI localization (Fig 5B). Although FtsWM269K was unable to support division, it still recruited GFP-FtsI to presumptive division sites in the filaments, indicating that the divisome was assembled. Furthermore, bacterial two hybrid analysis showed that M269K and A270T did not affect the interaction between FtsW and FtsI or between FtsW and FtsQLB (S4 Fig). The active mutant M269I also displayed a similar interaction with these divisome proteins. Thus, the mutations (active or inactive) did not detectably affect the interaction between FtsW and other divisome proteins, indicating that they likely affect the activation of FtsW.

Isolation of FtsWE289G and FtsIK221I as hyperactive division mutants that bypass FtsN

In a recent study, we isolated dominant negative FtsL mutants that block cell division [22]. These mutants support assembly of the divisome but are unable to divide because they are likely unable to interact with FtsI in response to FtsN [22]. Such mutants are suppressed by the hyperactive ftsWM269I mutation which no longer requires the activation signal from FtsN [22]. To isolate additional active ftsW and ftsI mutations, we screened FtsW and FtsI mutant libraries for suppressors of one of these FtsL mutants (FtsLE87K). We isolated one mutation in ECL4 of FtsW (E289G) and one in the pedestal domain of FtsI (K211I) (Fig 1A). As previously shown and in Figs 6 and S5, FtsLE87K and another inactive mutant FtsLL86F were unable to complement an FtsL depletion strain when expressed from an arabinose-inducible promoter on a plasmid. However, expression of FtsWE289G or FtsIK211I from an IPTG-inducible promoter on a compatible plasmid rescued the growth of the strain when FtsLE87K or FtsLL86F were expressed, indicating that they are suppressed.

Fig 6. FtsIK211I and FtsWE289G rescue inactive FtsL mutants.

Fig 6

Plasmids pDSW208, pSEB429 (pDSW208, P204::ftsW), pLY91 (pDSW208, P204::ftsI) or their derivatives carrying different ftsW or ftsI alleles were transformed into strain SD399 (W3110, ftsL::kan /pSD256) harboring plasmid pSD296-L86F (pBAD33, PBAD::ftsLL86F) or pSD296-E87K (pBAD33, PBAD::ftsLE87K) and transformants selected on LB plates with antibiotics and glucose. The next day, a single colony of each resulting strain was subject to spot tests. Plates were incubated at 30°C for 24 hours or at 42°C overnight and photographed.

To prove that FtsWE289G and FtsIK211I were active division mutants, we tested if they suppressed other mutations that blocked septal PG synthesis. First, we tested the ATPase defective mutant of FtsEX, FtsED162NX, which was previously shown to block septal PG synthesis and to be suppressed by FtsWM269I [20,23,33]. As shown in S6A Fig, overexpression of FtsEXD162N blocked the growth of the wild type strain but not a strain carrying the ftsWE289G mutation. Notably, FtsWE289G’s resistance to FtsED162NX was even greater than FtsWM269I, suggesting that FtsWE289G is a stronger activation mutant than FtsWM269I. A strain carrying the ftsIK211I mutation also displayed resistance to FtsED162NX (S6B Fig), consistent with it being an activation mutation.

Next, we tested if FtsWE289G and FtsIK211I could suppress the depletion of FtsN. As shown in S7 Fig, overexpression of FtsWE289G or FtsIK211I in an FtsN depletion strain fully rescued the growth defect, indicating that they suppressed the depletion of FtsN. To further test the strength of FtsWE289G and FtsIK211I, we checked whether they could bypass ftsN by transducing ftsN::kan into strains carrying these mutations. FtsIK211I was able to bypass ftsN on LB with 1% NaCl at 42°C (but not at 37°C) when it was overexpressed but not at the chromosomal level (S8 Fig). In liquid culture, ftsIK211I ftsN::kan cells grew poorly and were filamentous even when ftsIK211I was overexpressed (Fig 7A). On the other hand, a chromosomal copy of ftsWE289G was sufficient to bypass FtsN even on LB with 0.5% NaCl and these transductants grew well upon restreaking (S8B Fig). Inspection of ftsWE289G ftsN::kan cells revealed that they are only slightly longer than the wild type cells (Fig 7B), indicating that FtsN was largely bypassed.

Fig 7. FtsIK211I and FtsWE289G bypass FtsN.

Fig 7

(A) Morphology of WT and FtsIK211I cells with or without FtsN. Overnight cultures of W3110, LYA8 (W3110, leu::Tn10 ftsIK211I) and LYA9/pLY105 [W3110, leu::Tn10 ftsN::kan ftsIK211I/pLY105 (P204::ftsIK211I)] were diluted 1:100 in fresh LB medium with antibiotics and grown at 42°C. 60 μM IPTG was added to the culture of LYA9/pLY105. 2 hours later, samples were taken for photography. The scale bar is 5 μm. (B) Morphology of WT and FtsWE289G cells with or without FtsN. Overnight cultures of W3110, SD488, SD264 (W3110, leu::Tn10 ftsN::kan/pBL154 (pSC101ts, Psyn::ftsN)] and SD530 (W3110, leu::Tn10 ftsN::kan ftsWE289G) were diluted 1:100 in fresh LB medium with antibiotics and grown at 37°C. Samples were taken for photography 2 hours later. The scale bar is 5 μm.

We also tested additional substitutions of E289 of FtsW (E289Q, E289L and E289R) and K211 of FtsI (K211A, K211T, K211F, K211E) to see if they could rescue the growth of the FtsN depletion strain. Unlike substitutions at the M269 position of FtsW, which could be beneficial or detrimental for cell division, substitutions at the E289 position did not significantly affect the function of FtsW. Likewise, substitutions at K211 did not affect FtsI function. As shown in S9 and S10 Figs, all tested FtsW and FtsI mutants were functional in a complementation test, but only FtsWE289G and FtsIK211I could rescue the FtsN depleted strain. Thus, similar to ftsWM269I, only very specific mutations (ftsWE289G and ftsIK211I) gain the ability to bypass FtsN.

Lastly, we tested if the ftsWE289G and ftsIK211I mutations affected the interaction of FtsW or FtsI with other divisome proteins using the bacterial two hybrid assay. As shown in S4B Fig, ftsWE289G and ftsIK211I did not detectably affect the interaction between FtsW or FtsI and other division proteins (FtsL, FtsB, FtsQ and FtsI or FtsW). Thus, these two mutations are unlikely to increase the activity of FtsW in vivo by enhancing their interaction with other divisome proteins.

Epistatic analysis of the division mutations confirms the signaling cascade for FtsWI activation

Our recent study on the role of FtsL in E. coli cell division suggests that the periplasmic signaling cascade for FtsWI activation follows the order FtsN>FtsQLB>FtsI>FtsW [22]. In this study, and consistent with this model, we found several active mutants of FtsI and FtsW that suppressed inactive FtsL mutants and bypassed FtsN [22]. If the model is correct, active ftsW mutations should also suppress ftsI mutations deficient in activation as they would bypass this step. Several mutations in the pedestal domain of FtsI (G57D, S61F, L62P and R210C) were reported to affect the localization of FtsN [34], but our recent study suggested that these mutations likely affect the ability of FtsI to activate FtsW [22]. Thus, we tested if FtsWE289G could suppress these ftsI mutations. As shown in Fig 8, these FtsI mutants were unable to complement a strain carrying the temperature-sensitive ftsI23 mutation at 37°C. However, growth was restored for three of the four mutants (G57D, S61F and R210C) if FtsWE289G was present. A failure to rescue the fourth mutant (L62P) may be due to the proline substitution which often affects protein structure substantially. Thus, FtsWE289G was dominant over three of these inactive FtsI mutations.

Fig 8. Overexpression of FtsWE289G suppresses FtsI mutations defective in activation of septal PG synthesis.

Fig 8

Plasmid pDSW208, pSEB429 (pDSW208, P204::ftsW) or its derivatives carrying different ftsW alleles were co-transformed with plasmid pBAD33 carrying different ftsI alleles into strain MCI23 ΔrecA (MC4100, ftsI23 recA::spec). Transformants were selected on LB plates with antibiotics and glucose at 30°C. The next day, a single colony of each resulting strain was subjected to a spot test.

Based on our analysis above, FtsWM269K and FtsWA270T are likely defective in the activation step with FtsWM269K being more severely affected than FtsWA270T. If the signaling cascade model is correct, activation mutations in upstream proteins in the cascade should not suppress FtsWM269K or FtsWA270T. We tested two active mutations in the periplasmic cascade, one in FtsB (E56A) and one in FtsI (K211I). As expected, FtsWM269K was not suppressed by an active ftsBE56A mutation or when FtsIK211I was overexpressed (Fig 9). However, the growth of the strain containing FtsWA270T was restored in the presence of FtsBE56A or when FtsIK211I was overexpressed. We also tested if overexpression of FtsN or the presence of the ftsAR286W mutation, both of which enhance activation of FtsWI, could suppress FtsWM269K or FtsWA270T. As shown in S11 Fig, the growth defect of FtsWA270T but not FtsWM269K was suppressed. Thus, the weakly defective mutant FtsWA270T still responds to activation by FtsN or by activation mutations in the upstream proteins in the signaling cascade, but the severely defective mutant FtsWM269K is unable to respond. Altogether, these results support that the signaling cascade flows from FtsN>FtsQLB>FtsI>FtsW and confirm that mutations in downstream proteins are dominant over mutations in upstream proteins.

Fig 9. FtsBE56A and FtsIK211I suppress FtsWA270T but not FtsWM269K.

Fig 9

(A) Spot test to assess the ability of FtsBE56A to suppress FtsWA270T and FtsWM269K. Plasmid pDSW208, pSEB429 or its derivatives carrying different ftsW alleles were transformed into strain SD367 [TB28, ftsW::kan/pSD257(pSC101ts, ftsW)] or SD368 [TB28, ftsBE56A, ftsW::kan/pSD257(pSC101ts, ftsW)] on LB plates with ampicillin, kanamycin and spectinomycin at 30°C. The spot test was performed as in Fig 5. (B) Spot test of the ability of FtsIK211I to suppress FtsWA270T and FtsWM269K. The test was done in strain SD292 [W3110, ftsW::kan recA56 slrD::Tn10 /pSD257 (pSC101ts, ftsW)] containing plasmid pLY91 (P204::ftsI) or pLY105 (P204::ftsIK211I). SD292 was transformed with plasmid pBAD33 carrying different ftsW alleles and transformants selected at 30°C. Test was done as (A) on LB plates with or without arabinose and IPTG at 30°C and 42°C.

ftsWE289G and ftsIK211I are intragenic suppressors of inactive FtsW and FtsI mutants, respectively

In addition to the epistatic analysis of the active and inactive mutations between different division proteins, we also tested the epistatic interaction between the active and inactive mutations of FtsI and FtsW. As shown in Fig 10A, the inactive FtsI mutants (G57D, S61F, L62P and R210C) expressed from an IPTG-inducible promoter on a plasmid were unable to complement the ftsI23ts strain at 37°C. However, adding the K211I mutations to these alleles, except for FtsIL62P, rescued the growth of the ftsI23ts strain, indicating that K211I is an intragenic suppressor of these inactivating ftsI mutations. However, it is noticeable that a basal level of expression of FtsI or FtsIK211I from the plasmid was sufficient to complement the ftsI23ts strain, whereas a higher concentration of IPTG was required for complementation with the double mutants, indicating that the inactive mutations reduced the efficiency of FtsIK211I. Similarly, the ftsWE289G mutation suppressed the ftsWM269K and ftsWA270T mutations. As shown in Fig 10B, the FtsW depletion strain was unable to grow on plates without arabinose, however, growth was restored by the presence of a plasmid that expressed either wild type FtsW or FtsWE289G from an IPTG-inducible promoter (even in the absence of IPTG, indicating that basal expression is sufficient). With FtsWA270T growth was restored at 15 μM IPTG consistent with it being somewhat deficient. However, adding E289G to the deficient alleles (FtsWM269K/E289G and FtsWA270T/E289G) resulted in the complementation of the depletion strain. FtsWA270T/E289G did not require IPTG for complementation, whereas FtsWM269K/E289G needed 15 μM IPTG for optimal growth. Thus, E289G rescued both M269K and A270T, although M269K reduced the activity of E289G.

Fig 10. ftsIK211I and ftsWE289G are intragenic suppressors of inactive FtsI and FtsW mutants respectively.

Fig 10

(A) ftsIK211I suppresses inactive FtsI mutations. To test the ability of various FtsI mutants to be rescued by K211I, plasmid pDSW208, pLY91 (pDSW208, P204::ftsI) or its derivatives carrying different alleles of ftsI were transformed into strain MCI23ΔrecA (W3110, recA::spec, ftsI23) at 30°C. Complementation test was done at 42°C (to inactivae FtsI23) and in the presence of IPTG to induce the ftsI alleles contained on the plasmids. (B) ftsWE289G suppresses inactive FtsW mutants. To test the ability of E289G to rescue deficient FtsW alleles, plasmid pDSW208, pSEB429 or its derivatives carrying different alleles of ftsW were transformed into strain SD237 (W3110, leu::Tn10, ftsW::kan/pDSW406 [pBAD33, PBAD::ftsW]) on LB plates with ampicillin, kanamycin, chloramphenicol and 0.2% arabinose at 37°C. The complementation test was done by removing arabinose (to deplete WT FtsW) and adding IPTG to induce the ftsW alleles on the plasmids.

Mutations affecting activation of SEDS-bPBP complexes cluster to the interaction interface between the ECL4 of SEDS proteins and the pedestal domain of bPBPs

The residues in FtsW and FtsI that correspond to the mutations analyzed here are either located in the ECL4 of FtsW or in the pedestal domain of FtsI. The corresponding domains have been proposed to play a critical role in activation of the RodA-PBP2 complex [16]. This prompted us to map all known mutations that result in activation or inactivation of the two SEDS-bPBP complexes to the TtRodA-PBP2 structure. These include those in E. coli FtsW (M269I/K/E, A270T and E289G) and FtsI (G57D, S61F, L62P and R210C, K211I), those in C. crescentus FtsW (A31K, F145L, T180A and A246T), those in E. coli RodA (A234T and T249P) and PBP2 (Q51L, T52N and L61R), and those in T. thermophilus PBP2 (L43E and A186E) (Table 1). The residues altered by most of these mutations, regardless of whether they are active or inactive, are located in a small region of the interaction interface between the ECL4 of TtRodA and the pedestal domain of TtPBP2 or its proximal region (Fig 11). EcFtsWE289G and EcRodAT249P lie within a small unstructured region of ECL4 which is also near the interaction interface. The location of these mutations on the TtRodA-PBP2 structure support a model in which the pedestal domain of bPBPs is involved in activation of their cognate SEDS proteins via ECL4 and suggest that these residues are critical for the interaction. Notably, some of the same substitutions produced opposite phenotypes in different organisms, for example, EcFtsWA270T is partially defective, but CcFtsWA246T and EcRodAA234T are hyperactive. Also, many mutations are right next to each other but produce opposite phenotypes, for example, FtsIR210C is inactive for division, but FtsIK211I is more potent for cell division. This suggests that local subtle re-arrangements of these domains lead to the activation or inactivation of the SEDS-bPBP complex. It is also worthwhile to mention that previous evolutionary sequence covariation analyses revealed strong evolutionary coupling between residues within the ECL4 of FtsW and the pedestal domain of FtsI [3537]. Since mutations that alter these residues do not affect the interaction they must affect the activation.

Table 1. Active (orange) and inactive (magenta) FtsW/RodA and FtsI/PBP2 mutations.

EcFtsW CcFtsW EcRodA TtRodA
Corresponding residues of mutations in FtsW/RodA T52 A31K I23 L18
L164 F145L I128 L122
V201 T180A S163 A156
M269I/K/E I245 I233 I226
A270T A246T A234T A227
V285 V261 T249P S242
E289G R264 E254 G247
Corresponding residues of mutations in FtsI/PBP2 EcFtsI CcFtsI EcPBP2 TtPBP2
N18 I45V A15 NA
V54 F71 Q51L A35
K55 S72 T52N L36
G57D A74 S54 S38
S61F/P G78 R58 Y42
L62P G79 I59 L43E
V64 A81 L61R T45
I208 NA E226 A186E
R210C NA E228 E188
K211I NA V229 V189

NA: Not available (CcFtsI lacks the region containing the corresponding residues in the alignment)

Fig 11. Location of residues on the TtRodA-PBP2 structure that correspond to mutations that affect the activity of SEDS-bPBP protein complexes.

Fig 11

TtRodA is colored green, whereas TtPBP2 is colored cyan (only a part of the pedestal domain is shown). Mutations that increased the activity of FtsWI or RodA-PBP2 are colored orange, whereas mutations that inhibit the activity of these SEDS-bPBP protein complex are colored magenta. The FtsW putative catalytic residue is colored red. Most of the active/inactive mutations are located at the interaction interface between ECL4 of TtRodA and the tip of the lower part of the pedestal domain of TtPBP2.

Discussion

A key step in bacterial cell division is the activation of septal PG synthesis at the Z ring. In E. coli and many gram-negative bacteria, this is triggered by FtsN, the last essential division protein recruited to the Z ring [2426]. Although FtsN binds to and stimulates the activity the class A penicillin binding protein PBP1b [5,6,9,10], which contributes to septal PG synthesis (4), the main function of FtsN is to activate the essential septal PG synthase FtsWI. FtsN does this by initiating two parallel signaling pathways, one in the cytoplasm and one in the periplasm (Fig 1B). In the cytoplasm, the cyto domain of FtsN interacts with FtsA to switch it to an active conformation which contributes to FtsWI activation by an unknown mechanism [1,18,27]. In the periplasm, the E domain of FtsN acts through FtsQLB, likely causing a conformational change such that the AWI domain of FtsL becomes available to interact with FtsI which stimulates the activity of FtsW [1,18,19,22,27]. This proposed activation pathway is strikingly similar to that of the analogous RodA-PBP2 complex despite the regulatory proteins being completely unrelated. In this complex MreC interacts with the pedestal domain of PBP2 and is proposed to switch the complex to the active conformation [15,16,38,39]. However, a detailed mechanism by which these SEDS-bPBPs are stimulated by their activators is still not clear. The ftsW and ftsI mutations isolated and characterized here that affect their activation in vivo are confined to the interface of the pedestal domain of FtsI and ECL4 of FtsW. Our results are consistent with the proposed activation mechanism for FtsWI [16,21] and provide new insights into the working mechanism of the SEDS-bPBP complexes.

Previous studies showed that mutations in the CCD domain of FtsB or FtsL enable cells to divide with reduced or no FtsN function [1820], whereas mutations in the AWI domain of FtsL (L86F, E87K), which lie on the opposite side of a putative helix encompassing the CCD domain, abolish FtsQLB’s ability to activate septal PG synthesis in vivo and to stimulate FtsWI in vitro [21,22]. However, these inactive FtsL mutations are suppressed by a mutation in FtsW (M269I) which was isolated as a suppressor of an ATPase mutant of FtsEX and found to tolerate the depletion of FtsN [20,22]. Here we show that this mutation contains a unique substitution that allows the bypass of FtsN when overexpressed indicating input from FtsN is no longer required. However, drastic substitutions at the M269 position (M269K/E) result in inactive FtsW proteins that are key for teasing out the signaling cascade for FtsWI activation.

Two additional mutations were isolated that suppress these inactive FtsL mutations, one in the ECL4 of FtsW (E289G) and one in the pedestal domain of FtsI (K211I). Notably, the ftsWE289G mutation was also isolated as a suppressor of ftsN deletion by other groups [4]. Both of these mutants bypass the essentiality of FtsN indicating that they are active mutants. They also suppress the ATPase mutant of FtsEX that blocks the cytoplasmic signal from FtsN. Strikingly, cells with a single copy of ftsWE289G allows cells to divide almost normally without FtsN. FtsWE289G can also suppress FtsI mutants (G57D, S61F and R210C) defective in activation in vivo. However, none of the reported active mutants of the upstream proteins can suppress an FtsW mutant (M269K) severely defective in activation, although they are able to suppress one (A270T) that is weakly defective. These results suggest that FtsWM269K is locked in an inactive state and are in agreement with the model in which the periplasmic signaling cascade for FtsWI activation follows the order: EFtsN>FtsQLB (FtsLAWI)>FtsI>FtsW [22]. Mutations in upstream proteins of the signaling cascade can block the activation of FtsWI, but once FtsW is in the active conformation (induced by the active mutations E289G or M269I reported here), this FtsN-triggered activation signaling cascade can be bypassed.

This signaling cascade (EFtsN>FtsQLB [FtsLAWI]>FtsI>FtsW) can explain why FtsI homologs in several Gram-positive organisms are essential even though their transpeptidase activity is not [40,41]. In Bacillus subtilis, cells continue to divide in the presence of a β-lactam that blocks the transpeptidase activity of the FtsI homolog (PBP2B) and a catalytically inactive mutant of PBP2B supported cell division [40]. Under these circumstances, the transpeptidase activity required for crosslinking PG glycan strands synthesized by FtsW is likely provided by another nonessential PBP (PBP3), which localizes to the division site and becomes essential only when the transpeptidase activity of PBP2B is blocked [40]. Comparable results were obtained in Staphylococcus aureus, in which introduction of a point mutation in the transpeptidase active site of the FtsI homolog (PBP1) did not result in a division block but the gene could not be deleted [41]. We suggest that the essential role of the FtsI homologs in these organisms is to transmit the activation signal from FtsLAWI to FtsW to start polymerization of PG glycan strands. Thus, cells can still divide even when FtsI homolog is inhibited by a β-lactam because FtsW is still activated and another PBP crosslinks the newly synthesized PG glycan strands. However, in E. coli, which lacks an accessory PBP, inhibition of the transpeptidase activity of FtsI results in the futile cycle of septal PG synthesis by FtsW [42].

How FtsI stimulates the activity of FtsW is not currently clear. Previous studies on the RodA-PBP2 complex indicated that the interaction between the pedestal domain of bPBP and the ECL4 of their cognate SEDS protein plays a critical role in activating the polymerization activity of the SEDS proteins [16]. In support of this, mutations in the ECL4 of RodA or in the pedestal domain of PBP2 activate the complex [15,17]. Similarly, here we found that mutations in the ECL4 of FtsW can lock the protein in an inactive state (M269K) that no longer responds to the activation by FtsN or in an active state (E289G and to a less extent M269I) that no longer requires FtsN for division. Mutations in the pedestal domain of FtsI can also activate (K211I) or inactivate (G57D, S61F, L62P and R210C) the FtsWI complex in vivo. Such mutations are quite unique and are unlikely to be isolated by site-directed mutagenesis. In BTH assays they do not detectably affect the interaction of FtsW with FtsI or their interaction with other divisome components. However, it is highly likely that these mutations, which are clustered to a small region at the interaction interface between the pedestal domain of FtsI and ECL4 of FtsW, lock the complex in an active or inactive state (Fig 10). This change will be difficult to detect using classical genetic or biochemical approaches because previous work on the RodA-PBP2 complex indicates that this interaction interface lacks specific interactions and is transient and flexible [16]. Nonetheless, the isolation of active mutations in both FtsWI and RodA-PBP2 at the same positions suggest that they are activated in similar ways by completely unrelated proteins, which likely modulate the interface between the SEDS protein and the bPBP.

Biochemical characterization of the FtsW and FtsI mutations studied here will be key to understanding their effect on the FtsWI complex, but our genetic analysis provides some clues. Analysis of the substitutions at the 269 position of FtsW suggests that a hydrophobic interaction at this position is critical for FtsWI to transition between the active and inactive conformations. A strong hydrophobic interaction will favor the protein in the active form, whereas loss of this hydrophobic interaction will favor the inactive form. On the other hand, the negative charge of E289 does not seem to be important for FtsW function as even changing it to arginine only slightly affects its function. However, only the E289G substitution can lock FtsW in the active form and surprisingly, it is epistatic to the M269K mutation that locks the protein in the inactive form. Similarly, the positive charge of K211 of FtsI is not essential for its function, but only K211I produces an active FtsI protein and suppresses nearby inactive FtsI mutations. These observations suggest that subtle local re-arrangements of the FtsWI complex, likely involving the region around M269-A270 and E289 of FtsW and region around K211 of FtsI, are critical for the stabilization of the active and inactive conformations. Since these mutations appear to lock FtsWI in the active/inactive conformation, they should be useful for structural and biochemical analysis of the FtsWI complex to reveal details of the activation mechanism.

Materials and methods

Media, bacterial strains, plasmids and growth conditions

Cells were grown in LB medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl and 0.05 g/L thymine), LB medium without NaCl or 1% NaCl at indicated temperatures. When needed, antibiotics were used at the following concentrations: ampicillin  =  100 μg/ml; spectinomycin  =  25 μg/ml; kanamycin  =  25 μg/ml; tetracycline  =  25 μg/ml; and chloramphenicol  =  20 μg/ml. Strains, plasmids and primers used in this study are listed in S1 Table, S2 Table and S3 Table, respectively. Construction of strains and plasmids is described in detail in S1 Text with the primers listed in S3 Table.

BTH assay

To detect the interaction between FtsW/FtsI or its mutants and other division proteins, appropriate plasmid pairs were co-transformed into BTH101. The next day, single colonies were resuspended in 1 ml LB medium, and 3 μL of each aliquot was spotted on LB plates containing ampicillin, kanamycin, 40 μg/ml X-gal and 100 μM IPTG. Plates were incubated at 30°C overnight before imaging.

Localization of GFP-fusion proteins

Localization of FtsW-L60-GFP. Overnight cultures of SD237 [W3110, leu::Tn10 ftsW::kan/pDSW406 (PBAD::ftsW, cat)] carrying plasmid pDSW210 (P206::gfp) or pSD247 (P206::ftsW-l60-gfp) and its derivatives were diluted 1:100 in fresh LB medium with antibiotics and 0.2% arabinose, grown at 30°C for 2 h. Cells were then collected by centrifugation and washed twice with fresh LB and resuspended in the same volume of LB medium. These arabinose-free culture were then diluted 1:10 in fresh LB medium and IPTG was added to a final concentration of 60 μM. 4 hours post removal of arabinose and induction with IPTG, cells were immobilized on 2% agarose pad for photograph.

Localization of GFP-FtsI. Overnight cultures of SD288 [W3110, ftsW::kan gfp-ftsI/pSD257 (pSC101ts, ftsW, Spc)] carrying plasmid pBAD33 or pDSW406 (pBAD33, PBAD::ftsW) and its derivatives from 30°C were diluted 100X in fresh LB medium with antibiotics, grown at 30°C for 2 h. The cultures were then diluted 1:10 in fresh LB medium with antibiotics, 0.2% arabinose and 10 μM IPTG and grown at 37°C for 3 hours. Cells were immobilized on 2% agarose pad for photograph.

Creation of FtsW and FtsI mutant library and screen for suppressors of dominant-negative FtsL mutants

Creation of FtsW and FtsI mutant libraries. ftsW was subjected to random PCR mutagenesis using the primer 5-NcoI-ftsW and 3-ftsW-HindIII and plasmid pSEB429 (pDSW208, P204::ftsW). Gel purified PCR product was digested with NcoI and HindIII and ligated into pSEB429 digested with the same enzymes. Ligation product was transformed into JS238 competent cells and plated on LB plates with ampicillin and glucose. About 20,000 transformants were pooled together and plasmids were isolated and stocked. FtsI mutant library was constructed similarly using primer pair pLY91-I-F and pLY91-I-R and plasmid pLY91 as a template.

Screen for suppressors of dominant-negative FtsL mutants. The mutagenized pSEB429 (pSEB429M) or pLY91 (pLY91M) was transformed into strain SD399 [W3110, ftsL::kan / pSD256 (pSC101ts, ftsL, aadA)] harboring plasmid pSD296-E87K (pBAD33, PBAD::ftsLE87K) and suppressors of FtsLE87K were selected on LB plates with antibiotics, 0.2% arabinose and 60 μM IPTG at 37°C. Strain SD399 could not grow at 37°C because plasmid pSD256 was not able to replicate, plasmid pSD296-E87K was not able to complement as FtsLE87K was not functional and toxic when induced with arabinose. Transformants that could grow on the selective plates thus likely contained plasmids expressing FtsW or FtsI mutants that could suppress the defect of FtsLE87K. In the screen with FtsW mutant library, 20 transformants were picked and restreaked on the selective plates for growth, 14 of them grew well. Plasmids were isolated from these 14 transformants and retransformed into strain SD399 carrying pSD296-E87K to confirm the suppression. Sequencing of the ftsW genes in these 14 suppressing plasmids showed that all of them harbored the E289G mutation (8 contained only the E289G mutation, 6 contained the E289G mutation as well as additional mutations). However, these other mutations were not further studied because the suppression of FtsLE87K was apparently due to the E289G mutation. In the screen with FtsI mutant library, 52 transformants were picked and restreaked on the selective plates for growth, 18 of them grew well. 17 of the plasmids isolated were confirmed to suppress FtsLE87K and sequencing of the ftsI gene on these plasmids showed that all of them harbor the K211I mutation.

Western blot

To measure the level of FtsW-L60-GFP mutants, overnight cultures of JS238 (wild type strain) harboring the respective plasmid were diluted 1:100 in LB medium with ampicillin and 30μM IPTG. After growth at 37°C for 2 hours, OD600 of each culture was measured and samples were taken for western blot. Cells were collected, resuspended in SDS-PAGE sample buffer and kept at room temperature for 30 min before they were loaded on the SDS-PAGE gel for analysis. Western blotting and detection of FtsW-L60-GFP were performed as previously described for other division proteins [43]. Anti-GFP antibody (Rockland Immunochemicals) was used at a dilution of 1/1000.

Supporting information

S1 Text. Construction of strains and plasmids.

(DOCX)

S1 Table. Bacterial strains used in this study.

(DOCX)

S2 Table. Plasmids used in this study.

(DOCX)

S3 Table. Primers used in this study.

(DOCX)

S1 Fig. Chromosomal FtsWM269I tolerates depletion of FtsN but cannot bypass FtsN.

(A) Spot test of the ability of FtsWM269I to tolerate the depletion of FtsN. Colonies of strain SD264 [W3110, ftsN::kan/pBL154 (pSC101ts, Psyn::ftsN, spc)] and SD265 [W3110, ftsWM269I ftsN::kan/pBL154 (pSC101ts, Psyn::ftsN, spc)] was resuspended in 1 ml of LB medium, serially diluted. 3μl of each dilution was spot on LB plates with antibiotics. Plates were incubated at 30°C for 24 hours or at 42°C overnight and photographed. (B) Morphology of strain SD264 and SD265 at 30 and 42°C. Overnight culture of SD264 and SD265 were diluted 1:100 in fresh LB medium with antibiotics and grown at 30°C for 2 hours. Samples were taken for photograph or further diluted in 1:10 in LB medium and shifted 42°C. The cultures were kept in exponential phase and samples were taken for photograph at indicated time points after the temperature shift. (C) P1 transduction to test the ability of FtsWM269I to bypass FtsN. P1 transduction of ftsN::kan from strain CH34/pMG20 (ftsN::kan) was attempted into S3 (W3110 leu::Tn10) and SD247 (W3110 leu::Tn10, ftsWM269I) following a standard procedure. Transductants were selected on LB plates with kanamycin and 1 mM sodium citrate. Plates were incubated at 30, 37, and 42°C overnight or up to 24 hours. Obtained transdutants were restreaked on LB medium with kanamycin and 1 mM sodium citrate for further growth. Only the results from 42°C was shown. Scale bar is 5 μm.

(TIF)

S2 Fig. P1 transduction to test the ability of FtsWM269I to bypass FtsN.

P1 transduction of ftsN::kan from strain CH34/pMG20 (ftsN::kan) was attempted into W3110 and SD247 (W3110 leu::Tn10, ftsWM269I) harboring plasmid pSEB417 (P204::ftsN), pSEB429 (P204::ftsW) or pSEB429-M269I (P204::ftsWM269I) following a standard procedure. Transductants were selected on LB plates with ampicillin, kanamycin, 1 mM sodium citrate and with or without 60 μM IPTG. Plates were incubated at 30°C up to 24 hours or 37 or 42°C overnight. Similar number of transductants were obtained for a control expressing FtsN and when FtsWM269I was induced with 60μM IPTG. Only the results from 37°C was shown.

(TIF)

S3 Fig. Alignment of the extracellular loop 4 (ECL4) of FtsW and RodA from diverse bacterial species.

Amino acid sequences were obtained from NCBI, aligned with Clustal Omega and then created using ESPRIPT: http://espript.ibcp.fr/. FtsW: E. coli (gi|2132970), K. pneumoniae (gi|597728208), S. flexneri (gi|110613701), Y. pestis (gi|115346361), B. thailandensis (gi|685745844), S. enterica (gi|205337406), P. aeruginosa (gi|15599609), L. pneumophila (gi|295650162), M. xanthus (gi|108761950), C. crescentus (gi|426019958), A. tumefaciens (gi|586950133), B. fragilis (gi|598888368), B. subtilis (gi|2493592), L. monocytogenes (gi|424013134), E. faecalis (gi|323480530), S. aureus (gi|384230086), M. tuberculosis (gi|613782430), C. glutamicum (gi|674168391), B. burgdoferi (gi|2493585), T. thermophiles (BAW00664.1). RodA: E. coli (gi|78101784), S. flexneri (gi|78101785), K. pneumonia (gi|499531772), S. enterica (gi|16501890), P. aeruginosa (gi|15599197), L. pneumophila (gi|148280678), B. thailandensis (gi|83652485), V. cholera (gi|126519168), Y. pestis (gi|115348295), C. crescentus (gi|220963725), B. subtilis (gi|732351), M. xanthus (gi|108462975), L. monocytogenes (gi|336024336), S. pneumoniae (gi|302638595), M. tuberculosis (gi|444893486), C. glutamicum (gi|62388939), T. thermophilus (WP_011228544.1).

(TIF)

S4 Fig

Bacterial two hybrid test of the interaction between FtsW (A) or FtsI (B) and other divisome proteins. Plasmids pairs were transformed into strain BTH101, the next day a single transformant of each resulting strain was resupended in 1 ml LB medium, 3μl of each culture was spot on LB plates containing antibiotics, 40 μg/ml X-gal and IPTG. Plates were incubated at 30°C for about 24 hours before photographing.

(TIF)

S5 Fig. Complementation test of FtsL mutants.

Plasmid pBAD33, or pSD296 (PBAD::ftsL) or its derivatives with different ftsL allele were transformed into strain SD399 (W3110, ftsL::kan /pSD256) harboring plasmid and transformants selected on LB plates with antibiotics and glucose. The next day, a single colony of each resulting strain was resuspended in 1 ml LB and serially diluted by 10. 3 μl of each dilution was spot on LB plates with appropriate antibiotics, with or without arabinose. Plates were incubated at 30°C for 24 hours or at 37°C overnight and photographed.

(TIF)

S6 Fig

FtsWE289G (A) and FtsIK211I (B) provide resistance to the division inhibitory activity of FtsED162NX. plasmid pSD221 (pEXT22, Ptac::ftsEX) or pSD221-D162N (pEXT22, Ptac::ftsED162NX) were transformed into strain W3110, SD247 (W3110, leu::Tn10, ftsWM269I), SD488 (W3110, leu::Tn10, ftsWE289G) or LYA8 (W3110, leu::Tn10, ftsIK211I). The next day, a single transformant of the resulting strains was resuspended in 1 ml BL medium and serially diluted in 10. 3 μl of each dilution was spotted on LB plates with antibiotics and with or with IPTG. Plates were incubated at 37°C overnight and photographed. Note that the resistance of SD488 to FtsED162NX was stronger than that of strain SD247.

(TIF)

S7 Fig

Overexpression of FtsIK211I (A) or FtsWE289G (B) tolerates the depletion of FtsN. Plasmid pDSW208, pLY91 (pDSW208, P204::ftsI), pSEB429 (pDSW208, P204::ftsW), or their derivatives carrying different ftsI or ftsW allele were transformed into strain SD264 [W3110, ftsN::kan /pBL154 (pSC101ts, ftsN)] and transformants selected on LB plates with antibiotics and glucose at 30°C. The test was performed as Fig 3B.

(TIF)

S8 Fig. FtsIK211I and FtsWE289G bypass FtsN.

(A) P1 transduction to test the ability of FtsIK211I (A) and FtsWE289G (B) to bypass FtsN. P1 transduction of ftsN::kan from strain CH34/pMG20 (ftsN::kan) was attempted into W3110, LYA8/pLY105 [W3110, leu::Tn10, ftsIK211I / P204::ftsIK211I] and SD488 (W3110, leu::Tn10, ftsWE289G) following a standard procedure. In the case of LYA8/pLY105, transductants were selected on LB plates with 1% NaCl, kanamycin, 1 mM sodium citrate and different concentration of IPTG at 30, 37, and 42°C. Transductants were only obtained at 42°C and they can only grow at 42°C when restreaked. For SD488, transductants were selected on LB plates with kanamycin and 1 mM sodium citrate at 30, 37, and 42°C. A similar number of transductants were obtained at all three temperatures and only the result from 37°C is shown. 4 transductants from SD488 (W3110, leu::Tn10, ftsWE289G) were restreaked on the same selection plates at 37°C and all grew well.

(TIF)

S9 Fig. FtsWE289G is a unique mutant that suppresses the depletion of FtsN.

(A) Complementation test of the FtsW mutants using strain SD237. (B) Spot test of the ability of FtsW mutants to rescue the growth of FtsN depletion strain at non-permissive condition. The tests were done as in Fig 3.

(TIF)

S10 Fig. FtsIK211I is a unique mutant that suppresses the depletion of FtsN.

(A) Complementation test of the FtsI mutants. Plasmids pDSW208, pLY91 (P204::ftsI) and pLY105 (P204::ftsIK211I) were transformed into strain PS413 (W3110, ftsI23). A single transformant of each resultant strain was resuspended in 1 ml LB and serially diluted by 10. 3 μl of each dilution was spot on LB plates with antibiotics and with or without IPTG. Plates were incubated at 30°C for 24 hours or at 42°C overnight and photographed. (B) Spot test of the ability of FtsI mutants to rescue the growth of FtsN depletion strain at non-permissive condition. Test was done as in S7B Fig.

(TIF)

S11 Fig. Overexpression of FtsN and FtsAR286W suppress FtsWA270T but not FtsWM269K.

(A) spot test of the ability of FtsN overexpression to suppress FtsWA270T and FtsWM269K. (B) Spot test of the ability of FtsAR286W to suppress FtsWA270T and FtsWM269K. The test was carried out as in Fig 9 but in strain SD295 [W3110, ftsW::kan recA56 slrD::Tn10 /pSD257 (pSC101ts, ftsW)] or SD390 [W3110, ftsAR286W, ftsW::kan recA56 slrD::Tn10 /pSD257(pSC101ts, ftsW)]. Note that FtsWA270T was unable to complement the FtsW depletion strain but FtsAR286W suppressed the defect completely. In addition, in the presence of FtsAR286W, less inducer was needed to induce wild type FtsW for complementation.

(TIF)

Acknowledgments

We thank members of the Du lab and the Lutkenhaus lab for comments and advice in preparing the manuscript.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This study was supported by funding from National Institute of General Medical Sciences (grant GM029764; https://www.nigms.nih.gov/) to JL, and funding from the National Natural Science Foundation of China (grant 32070032, http://www.nsfc.gov.cn/) and Wuhan University (https://www.whu.edu.cn/) to SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Du S, Lutkenhaus J. Assembly and activation of the Escherichia coli divisome. Mol Microbiol. 2017;105(2):177–87. 10.1111/mmi.13696 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Egan AJF, Errington J, Vollmer W. Regulation of peptidoglycan synthesis and remodelling. Nat Rev Microbiol. 2020;18(8):446–60. 10.1038/s41579-020-0366-3 [DOI] [PubMed] [Google Scholar]
  • 3.Taguchi A, Welsh MA, Marmont LS, Lee W, Sjodt M, Kruse AC, et al. FtsW is a peptidoglycan polymerase that is functional only in complex with its cognate penicillin-binding protein. Nat Microbiol. 2019;4(4):587–94. 10.1038/s41564-018-0345-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Yang X, McQuillen R, Lyu Z, Phillips-Mason P, De La Cruz A, McCausland JW, et al. A two-track model for the spatiotemporal coordination of bacterial septal cell wall synthesis revealed by single-molecule imaging of FtsW. Nat Microbiol. 2021. 10.1038/s41564-020-00853-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bertsche U, Kast T, Wolf B, Fraipont C, Aarsman ME, Kannenberg K, et al. Interaction between two murein (peptidoglycan) synthases, PBP3 and PBP1B, in Escherichia coli. Mol Microbiol. 2006;61(3):675–90. 10.1111/j.1365-2958.2006.05280.x [DOI] [PubMed] [Google Scholar]
  • 6.Muller P, Ewers C, Bertsche U, Anstett M, Kallis T, Breukink E, et al. The essential cell division protein FtsN interacts with the murein (peptidoglycan) synthase PBP1B in Escherichia coli. J Biol Chem. 2007;282(50):36394–402. 10.1074/jbc.M706390200 [DOI] [PubMed] [Google Scholar]
  • 7.Paradis-Bleau C, Markovski M, Uehara T, Lupoli TJ, Walker S, Kahne DE, et al. Lipoprotein cofactors located in the outer membrane activate bacterial cell wall polymerases. Cell. 2010;143(7):1110–20. 10.1016/j.cell.2010.11.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Typas A, Banzhaf M, van den Berg van Saparoea B, Verheul J, Biboy J, Nichols RJ, et al. Regulation of peptidoglycan synthesis by outer-membrane proteins. Cell. 2010;143(7):1097–109. 10.1016/j.cell.2010.11.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Boes A, Olatunji S, Breukink E, Terrak M. Regulation of the Peptidoglycan Polymerase Activity of PBP1b by Antagonist Actions of the Core Divisome Proteins FtsBLQ and FtsN. mBio. 2019;10(1). 10.1128/mBio.01912-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Boes A, Kerff F, Herman R, Touze T, Breukink E, Terrak M. The bacterial cell division protein fragment (E)FtsN binds to and activates the major peptidoglycan synthase PBP1b. J Biol Chem. 2020;295(52):18256–65. 10.1074/jbc.RA120.015951 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ikeda M, Sato T, Wachi M, Jung HK, Ishino F, Kobayashi Y, et al. Structural similarity among Escherichia coli FtsW and RodA proteins and Bacillus subtilis SpoVE protein, which function in cell division, cell elongation, and spore formation, respectively. J Bacteriol. 1989;171(11):6375–8. 10.1128/jb.171.11.6375-6378.1989 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Meeske AJ, Riley EP, Robins WP, Uehara T, Mekalanos JJ, Kahne D, et al. SEDS proteins are a widespread family of bacterial cell wall polymerases. Nature. 2016;537(7622):634–8. 10.1038/nature19331 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lara B, Ayala JA. Topological characterization of the essential Escherichia coli cell division protein FtsW. FEMS Microbiol Lett. 2002;216(1):23–32. 10.1111/j.1574-6968.2002.tb11409.x [DOI] [PubMed] [Google Scholar]
  • 14.Cho H, Wivagg CN, Kapoor M, Barry Z, Rohs PDA, Suh H, et al. Bacterial cell wall biogenesis is mediated by SEDS and PBP polymerase families functioning semi-autonomously. Nat Microbiol. 2016;1:16172. 10.1038/nmicrobiol.2016.172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rohs PDA, Buss J, Sim SI, Squyres GR, Srisuknimit V, Smith M, et al. A central role for PBP2 in the activation of peptidoglycan polymerization by the bacterial cell elongation machinery. PLoS Genet. 2018;14(10):e1007726. 10.1371/journal.pgen.1007726 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sjodt M, Rohs PDA, Gilman MSA, Erlandson SC, Zheng S, Green AG, et al. Structural coordination of polymerization and crosslinking by a SEDS-bPBP peptidoglycan synthase complex. Nat Microbiol. 2020;5(6):813–20. 10.1038/s41564-020-0687-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shiomi D, Toyoda A, Aizu T, Ejima F, Fujiyama A, Shini T, et al. Mutations in cell elongation genes mreB, mrdA and mrdB suppress the shape defect of RodZ-deficient cells. Mol Microbiol. 2013;87(5):1029–44. 10.1111/mmi.12148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Liu B, Persons L, Lee L, de Boer PA. Roles for both FtsA and the FtsBLQ subcomplex in FtsN-stimulated cell constriction in Escherichia coli. Mol Microbiol. 2015;95(6):945–70. 10.1111/mmi.12906 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tsang MJ, Bernhardt TG. A role for the FtsQLB complex in cytokinetic ring activation revealed by an ftsL allele that accelerates division. Mol Microbiol. 2015;95(6):925–44. 10.1111/mmi.12905 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Du S, Pichoff S, Lutkenhaus J. FtsEX acts on FtsA to regulate divisome assembly and activity. Proc Natl Acad Sci U S A. 2016;113(34):E5052–61. 10.1073/pnas.1606656113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Marmont LS, Bernhardt TG. A conserved subcomplex within the bacterial cytokinetic ring activates cell wall synthesis by the FtsW-FtsI synthase. Proc Natl Acad Sci U S A. 2020;117(38):23879–85. 10.1073/pnas.2004598117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Park KT, Du S, Lutkenhaus J. Essential Role for FtsL in Activation of Septal Peptidoglycan Synthesis. mBio. 2020;11(6). 10.1128/mBio.03012-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Du S, Pichoff S, Lutkenhaus J. Roles of ATP Hydrolysis by FtsEX and Interaction with FtsA in Regulation of Septal Peptidoglycan Synthesis and Hydrolysis. mBio. 2020;11(4). 10.1128/mBio.01247-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Addinall SG, Cao C, Lutkenhaus J. FtsN, a late recruit to the septum in Escherichia coli. Mol Microbiol. 1997;25(2):303–9. 10.1046/j.1365-2958.1997.4641833.x [DOI] [PubMed] [Google Scholar]
  • 25.Lutkenhaus J. FtsN—trigger for septation. J Bacteriol. 2009;191(24):7381–2. 10.1128/JB.01100-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gerding MA, Liu B, Bendezu FO, Hale CA, Bernhardt TG, de Boer PA. Self-enhanced accumulation of FtsN at Division Sites and Roles for Other Proteins with a SPOR domain (DamX, DedD, and RlpA) in Escherichia coli cell constriction. J Bacteriol. 2009;191(24):7383–401. 10.1128/JB.00811-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tsang MJ, Bernhardt TG. Guiding divisome assembly and controlling its activity. Curr Opin Microbiol. 2015;24:60–5. 10.1016/j.mib.2015.01.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bernard CS, Sadasivam M, Shiomi D, Margolin W. An altered FtsA can compensate for the loss of essential cell division protein FtsN in Escherichia coli. Mol Microbiol. 2007;64(5):1289–305. 10.1111/j.1365-2958.2007.05738.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Modell JW, Hopkins AC, Laub MT. A DNA damage checkpoint in Caulobacter crescentus inhibits cell division through a direct interaction with FtsW. Genes Dev. 2011;25(12):1328–43. 10.1101/gad.2038911 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Modell JW, Kambara TK, Perchuk BS, Laub MT. A DNA damage-induced, SOS-independent checkpoint regulates cell division in Caulobacter crescentus. PLoS Biol. 2014;12(10):e1001977. 10.1371/journal.pbio.1001977 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mercer KL, Weiss DS. The Escherichia coli cell division protein FtsW is required to recruit its cognate transpeptidase, FtsI (PBP3), to the division site. J Bacteriol. 2002;184(4):904–12. 10.1128/jb.184.4.904-912.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wissel MC, Wendt JL, Mitchell CJ, Weiss DS. The transmembrane helix of the Escherichia coli division protein FtsI localizes to the septal ring. J Bacteriol. 2005;187(1):320–8. 10.1128/JB.187.1.320-328.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Arends SJ, Kustusch RJ, Weiss DS. ATP-binding site lesions in FtsE impair cell division. J Bacteriol. 2009;191(12):3772–84. 10.1128/JB.00179-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wissel MC, Weiss DS. Genetic analysis of the cell division protein FtsI (PBP3): amino acid substitutions that impair septal localization of FtsI and recruitment of FtsN. J Bacteriol. 2004;186(2):490–502. 10.1128/jb.186.2.490-502.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ovchinnikov S, Kinch L, Park H, Liao Y, Pei J, Kim DE, et al. Large-scale determination of previously unsolved protein structures using evolutionary information. Elife. 2015;4:e09248. 10.7554/eLife.09248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Sjodt M, Brock K, Dobihal G, Rohs PDA, Green AG, Hopf TA, et al. Structure of the peptidoglycan polymerase RodA resolved by evolutionary coupling analysis. Nature. 2018;556(7699):118–21. 10.1038/nature25985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cong Q, Anishchenko I, Ovchinnikov S, Baker D. Protein interaction networks revealed by proteome coevolution. Science. 2019;365(6449):185–9. 10.1126/science.aaw6718 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Liu X, Biboy J, Consoli E, Vollmer W, den Blaauwen T. MreC and MreD balance the interaction between the elongasome proteins PBP2 and RodA. PLoS Genet. 2020;16(12):e1009276. 10.1371/journal.pgen.1009276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Contreras-Martel C, Martins A, Ecobichon C, Trindade DM, Mattei PJ, Hicham S, et al. Molecular architecture of the PBP2-MreC core bacterial cell wall synthesis complex. Nat Commun. 2017;8(1):776. 10.1038/s41467-017-00783-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sassine J, Xu M, Sidiq KR, Emmins R, Errington J, Daniel RA. Functional redundancy of division specific penicillin-binding proteins in Bacillus subtilis. Mol Microbiol. 2017;106(2):304–18. 10.1111/mmi.13765 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Reichmann NT, Tavares AC, Saraiva BM, Jousselin A, Reed P, Pereira AR, et al. SEDS-bPBP pairs direct lateral and septal peptidoglycan synthesis in Staphylococcus aureus. Nat Microbiol. 2019;4(8):1368–77. 10.1038/s41564-019-0437-2 [DOI] [PubMed] [Google Scholar]
  • 42.Cho H, Uehara T, Bernhardt TG. Beta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery. Cell. 2014;159(6):1300–11. 10.1016/j.cell.2014.11.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Du S, Henke W, Pichoff S, Lutkenhaus J. How FtsEX localizes to the Z ring and interacts with FtsA to regulate cell division. Mol Microbiol. 2019. 10.1111/mmi.14324 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Lotte Søgaard-Andersen, Daniel B Kearns

22 Feb 2021

Dear Dr Du,

Thank you very much for submitting your Research Article entitled 'Genetic analysis of the septal peptidoglycan synthase FtsWI complex supports a conserved activation mechanism for SEDS-bPBP complexes' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some concerns that we ask you address in a revised manuscript

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Daniel B. Kearns

Associate Editor

PLOS Genetics

Lotte Søgaard-Andersen

Section Editor: Prokaryotic Genetics

PLOS Genetics

Shishen,

Three reviewers (and myself) were very enthusiastic about your manuscript. We found it timely, important, and well-conducted. Nonetheless, the reviewers provide good comments for you to consider as part of a revision. Nice work, and thanks for submitting to PLoS Genetics.

Dan

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: This manuscript by Li et al provides significant further genetic evidence and molecular details supporting a model of interaction/ activation of SEDS family glycosyltransferase FtsW by its class b PBP partner FtsI during E. coli cell division. They further characterize a previously isolated activation mutant of FtsW (M269I) and isolate additional mutants of FtsW (E289G) and FtsI (K211I) that further clarify a main pathway of activation of E. coli divisome peptidoglycan synthesis (FtsN --> FtsL (in association with FtsQB) --> FtsI --> FtsW), with FtsA and FtsEX also figuring into this regulated septal cell wall synthesis. The authors do an excellent job of using genetics to tease out interactions between all of these players and a hierarchy of their activities, building/confirming existing models proposed for the SEDS/bPBP partner interactions in cell length growth (RodA/PBP2). Consideration of their results when mapping mutations onto RodA/PBP2 structure interactions likely analgous to FtsW/FtsI reveal that activation of FtsW through FtsI occurs via the extracellular loop 4 (ECL4) of FtsW with the 'pedestal domain' of FtsI, separate from regions responsible for recruiting these proteins to the divisome. At the same time, their results demonstrate that the specific residues within these domains that are most integral for activation show some variation between species.

Overall I believe the manuscript is solid, with conclusions well-supported by the data. I only have some minor comments:

- The initial results with the A270T mutation of FtsW are interesting and also become important for later portions of the paper in that it serves as a partially 'inactive' form. This is stated within lines 172 - 173, with reference to figure SF4, but seems a foundational piece of data that bears more stressing and explanation here. I would actually recommend that SF4 be made a regular figure given the importance of A270T later and that its 'defect' is otherwise not apparent to the reader.

- The caveat to lines 174 and 175 would be that the gfp adds to stability compared to a non-fused version of the mutants. The 'inactivity' of these even with the gfp though would be consistent with their statements/arguments. I would just clarify.

- The cells carrying ftsN::kan in Figure 2 panel B seem to be mostly lysing (pock-marked). Does the necessity of antibiotics here make this more prevalent perhaps? Doesn't seem to fully 'suppress' PG defects then?

- Has an M269L allele been attempted, would they predict that might act like the Ile version?

- Line 259. All substitutions affect protein structure by definition. Just add something like 'substantially'.

- Lines 262 - 264, it was unclear to me initially why one would necessarily predict this exactly. This may be in part due to my still not grasping at this point what the 'defect' with A270T was.

- In Figure 4 the GFP-FtsW and GFP-FtsI signal in the M269K background seems to be infrequent and particularly irregular. Is this really still able to localize to the divisome, or are we seeing residual preformed rings that never disassembled as FtsW was depleted (maybe still containing some residual W?) The GFP-FtsW label in panel A should also be put in.

- The text needs editing in terms of putting in commas. Several sentences are awkward or confusing without commas properly separating clauses, etc.

Reviewer #2: This paper from Li and co-workers investigates the activation of cell wall synthesis within the divisome by the FtsWI synthase complex. The authors use an elegant series of genetic experiments to show that amino acid substitutions in the pedestal domain of FtsI and extracellular loop 4 of FtsW can either lead to hyperactivation of the synthase or its inactivation. Epistasis studies provided additional support for the pathway of activation within the divisome triggered by FtsN flowing from FtsQLB to FtsI to FtsW. Mapping of the activating and inactivating changes in FtsWI to the structure of the related SEDS-bPBP cell wall synthase RodA-PBP2 from the elongation machinery provides evidence for a conserved activation mechanism between the two synthases as changes that activate RodA-PBP2 map to the same region of the structure. Overall, this is a very nice paper that makes an important contribution to our understanding of how cell wall synthesis is activated within morphogenic machines. I have only minor points to be addressed.

1) Line 67: evidences are > evidence is

2) Line 90: ...AWI domain of FtsL is LIKELY TO BE exposed...

3) Line 244-245: Thus, these two mutations do not... I think this statement is too strong since it is based solely on two-hybrid analysis. Please moderate it.

4) Line 271: ...the weak mutant... change to ...the weakly defective mutant...

5) Line 273: Similarly, it would be better to describe the other mutant as the "severely defective mutant".

6) Line 287: Change "inactive mutations" to "inactivating mutations".

7) Line 307: ...whether THEY are...

8) Table 1: The text is not colored as indicated in the legend.

9) Line 336: ...resulting in... is too strong. Change to "likely causing".

10) Line 410: I think you mean POSITIVE charge of K211

11) Some of the spot assay figures could be better labeled to make it easier for the reader to follow. For example, Fig. 5A, it is not clear from looking at the figure that FtsL is depleted by a temperature shift. Please review and modify figures accordingly to make them easier to follow.

Reviewer #3: 1. Could the authors clarify the relationship between two possible activation pathways, one form FtsN, and one from FtsEX, on the activation of FtsW? Are they independent and redundant of each other? FtsW superfission mutants M269I and E289G can suppress FtsE(D162N)X or FtsN depletion separately. Can they suppress both at the same time (FtsE(D162N)X + FtsN depletion)?

2. I am not sure about the statement that the transpeptidase activity of FtsI is not essential, Antibiotics such as Aztreonam specifically inhibits FtsI’s transpeptidase activity leads to the cease of cell division, long filamentation, and eventually death. I think I understand the authors’ point of view that another essential function of FtsI is to activate FtsW, for which FtsI’s transpeptidase activity is not required. This point should be clarified.

3. The authors’ observations that the negative charges of E289 and K211 are not essential are interesting. They imply that the interactions between FtsW and FtsI may not be typical electrostatic protein-protein interactions. Could the authors offer more specific insight regarding how this could be possible based on the structural model, other than “subtle local re-arrangements of the FtsWI complex”? for example, some type of structural model?

4. I am not sure about the epistatic analysis of FtsW-E289G on M269K and A270T. To me it is an effect of E289G overwriting M269K and A270T, but this overwriting function is not dependent on the presence of M269K or A270T. In other words, the super activation phenotype of W289G is not dependent on M269K or A270T, as it can compensate FtsW depletion. M269K reduced the activity of E289G, certainly indicating some type of interactions between the two sites but does not mean that one mutant is dependent on the other to function. Or am I understand the concept of epistasis in the wrong way?

Minor comments:

1. Lines 110-124: Including clarification in the text to Figs. S1A and S1B will allow readers to better match the text and figure for a better understanding.

2. Lines 276-296: Including clarification in the text to Figs. 9A and 9B will allow readers to better match the text and figure for a better understanding.

3. Page 17: In the Table 1 description it lists “Active (green)” however there is no green text in the table or text.

4. Figure 10 (structure with mutations) and Table 1 (mutations) are related, but minor changes will make the connection stronger. Figure 10 has increased activity mutations in orange, inhibiting mutations in magenta, and the catalytic residue in red. Table 1 has active mutations in green. Keeping a consistent color scheme between the structure figures and the table would be helpful.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Decision Letter 1

Lotte Søgaard-Andersen, Daniel B Kearns

18 Mar 2021

Dear Dr Du,

We are pleased to inform you that your manuscript entitled "Genetic analysis of the septal peptidoglycan synthase FtsWI complex supports a conserved activation mechanism for SEDS-bPBP complexes" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Daniel B. Kearns

Associate Editor

PLOS Genetics

Lotte Søgaard-Andersen

Section Editor: Prokaryotic Genetics

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-21-00068R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Lotte Søgaard-Andersen, Daniel B Kearns

9 Apr 2021

PGENETICS-D-21-00068R1

Genetic analysis of the septal peptidoglycan synthase FtsWI complex supports a conserved activation mechanism for SEDS-bPBP complexes

Dear Dr Du,

We are pleased to inform you that your manuscript entitled "Genetic analysis of the septal peptidoglycan synthase FtsWI complex supports a conserved activation mechanism for SEDS-bPBP complexes" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Alice Ellingham

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Construction of strains and plasmids.

    (DOCX)

    S1 Table. Bacterial strains used in this study.

    (DOCX)

    S2 Table. Plasmids used in this study.

    (DOCX)

    S3 Table. Primers used in this study.

    (DOCX)

    S1 Fig. Chromosomal FtsWM269I tolerates depletion of FtsN but cannot bypass FtsN.

    (A) Spot test of the ability of FtsWM269I to tolerate the depletion of FtsN. Colonies of strain SD264 [W3110, ftsN::kan/pBL154 (pSC101ts, Psyn::ftsN, spc)] and SD265 [W3110, ftsWM269I ftsN::kan/pBL154 (pSC101ts, Psyn::ftsN, spc)] was resuspended in 1 ml of LB medium, serially diluted. 3μl of each dilution was spot on LB plates with antibiotics. Plates were incubated at 30°C for 24 hours or at 42°C overnight and photographed. (B) Morphology of strain SD264 and SD265 at 30 and 42°C. Overnight culture of SD264 and SD265 were diluted 1:100 in fresh LB medium with antibiotics and grown at 30°C for 2 hours. Samples were taken for photograph or further diluted in 1:10 in LB medium and shifted 42°C. The cultures were kept in exponential phase and samples were taken for photograph at indicated time points after the temperature shift. (C) P1 transduction to test the ability of FtsWM269I to bypass FtsN. P1 transduction of ftsN::kan from strain CH34/pMG20 (ftsN::kan) was attempted into S3 (W3110 leu::Tn10) and SD247 (W3110 leu::Tn10, ftsWM269I) following a standard procedure. Transductants were selected on LB plates with kanamycin and 1 mM sodium citrate. Plates were incubated at 30, 37, and 42°C overnight or up to 24 hours. Obtained transdutants were restreaked on LB medium with kanamycin and 1 mM sodium citrate for further growth. Only the results from 42°C was shown. Scale bar is 5 μm.

    (TIF)

    S2 Fig. P1 transduction to test the ability of FtsWM269I to bypass FtsN.

    P1 transduction of ftsN::kan from strain CH34/pMG20 (ftsN::kan) was attempted into W3110 and SD247 (W3110 leu::Tn10, ftsWM269I) harboring plasmid pSEB417 (P204::ftsN), pSEB429 (P204::ftsW) or pSEB429-M269I (P204::ftsWM269I) following a standard procedure. Transductants were selected on LB plates with ampicillin, kanamycin, 1 mM sodium citrate and with or without 60 μM IPTG. Plates were incubated at 30°C up to 24 hours or 37 or 42°C overnight. Similar number of transductants were obtained for a control expressing FtsN and when FtsWM269I was induced with 60μM IPTG. Only the results from 37°C was shown.

    (TIF)

    S3 Fig. Alignment of the extracellular loop 4 (ECL4) of FtsW and RodA from diverse bacterial species.

    Amino acid sequences were obtained from NCBI, aligned with Clustal Omega and then created using ESPRIPT: http://espript.ibcp.fr/. FtsW: E. coli (gi|2132970), K. pneumoniae (gi|597728208), S. flexneri (gi|110613701), Y. pestis (gi|115346361), B. thailandensis (gi|685745844), S. enterica (gi|205337406), P. aeruginosa (gi|15599609), L. pneumophila (gi|295650162), M. xanthus (gi|108761950), C. crescentus (gi|426019958), A. tumefaciens (gi|586950133), B. fragilis (gi|598888368), B. subtilis (gi|2493592), L. monocytogenes (gi|424013134), E. faecalis (gi|323480530), S. aureus (gi|384230086), M. tuberculosis (gi|613782430), C. glutamicum (gi|674168391), B. burgdoferi (gi|2493585), T. thermophiles (BAW00664.1). RodA: E. coli (gi|78101784), S. flexneri (gi|78101785), K. pneumonia (gi|499531772), S. enterica (gi|16501890), P. aeruginosa (gi|15599197), L. pneumophila (gi|148280678), B. thailandensis (gi|83652485), V. cholera (gi|126519168), Y. pestis (gi|115348295), C. crescentus (gi|220963725), B. subtilis (gi|732351), M. xanthus (gi|108462975), L. monocytogenes (gi|336024336), S. pneumoniae (gi|302638595), M. tuberculosis (gi|444893486), C. glutamicum (gi|62388939), T. thermophilus (WP_011228544.1).

    (TIF)

    S4 Fig

    Bacterial two hybrid test of the interaction between FtsW (A) or FtsI (B) and other divisome proteins. Plasmids pairs were transformed into strain BTH101, the next day a single transformant of each resulting strain was resupended in 1 ml LB medium, 3μl of each culture was spot on LB plates containing antibiotics, 40 μg/ml X-gal and IPTG. Plates were incubated at 30°C for about 24 hours before photographing.

    (TIF)

    S5 Fig. Complementation test of FtsL mutants.

    Plasmid pBAD33, or pSD296 (PBAD::ftsL) or its derivatives with different ftsL allele were transformed into strain SD399 (W3110, ftsL::kan /pSD256) harboring plasmid and transformants selected on LB plates with antibiotics and glucose. The next day, a single colony of each resulting strain was resuspended in 1 ml LB and serially diluted by 10. 3 μl of each dilution was spot on LB plates with appropriate antibiotics, with or without arabinose. Plates were incubated at 30°C for 24 hours or at 37°C overnight and photographed.

    (TIF)

    S6 Fig

    FtsWE289G (A) and FtsIK211I (B) provide resistance to the division inhibitory activity of FtsED162NX. plasmid pSD221 (pEXT22, Ptac::ftsEX) or pSD221-D162N (pEXT22, Ptac::ftsED162NX) were transformed into strain W3110, SD247 (W3110, leu::Tn10, ftsWM269I), SD488 (W3110, leu::Tn10, ftsWE289G) or LYA8 (W3110, leu::Tn10, ftsIK211I). The next day, a single transformant of the resulting strains was resuspended in 1 ml BL medium and serially diluted in 10. 3 μl of each dilution was spotted on LB plates with antibiotics and with or with IPTG. Plates were incubated at 37°C overnight and photographed. Note that the resistance of SD488 to FtsED162NX was stronger than that of strain SD247.

    (TIF)

    S7 Fig

    Overexpression of FtsIK211I (A) or FtsWE289G (B) tolerates the depletion of FtsN. Plasmid pDSW208, pLY91 (pDSW208, P204::ftsI), pSEB429 (pDSW208, P204::ftsW), or their derivatives carrying different ftsI or ftsW allele were transformed into strain SD264 [W3110, ftsN::kan /pBL154 (pSC101ts, ftsN)] and transformants selected on LB plates with antibiotics and glucose at 30°C. The test was performed as Fig 3B.

    (TIF)

    S8 Fig. FtsIK211I and FtsWE289G bypass FtsN.

    (A) P1 transduction to test the ability of FtsIK211I (A) and FtsWE289G (B) to bypass FtsN. P1 transduction of ftsN::kan from strain CH34/pMG20 (ftsN::kan) was attempted into W3110, LYA8/pLY105 [W3110, leu::Tn10, ftsIK211I / P204::ftsIK211I] and SD488 (W3110, leu::Tn10, ftsWE289G) following a standard procedure. In the case of LYA8/pLY105, transductants were selected on LB plates with 1% NaCl, kanamycin, 1 mM sodium citrate and different concentration of IPTG at 30, 37, and 42°C. Transductants were only obtained at 42°C and they can only grow at 42°C when restreaked. For SD488, transductants were selected on LB plates with kanamycin and 1 mM sodium citrate at 30, 37, and 42°C. A similar number of transductants were obtained at all three temperatures and only the result from 37°C is shown. 4 transductants from SD488 (W3110, leu::Tn10, ftsWE289G) were restreaked on the same selection plates at 37°C and all grew well.

    (TIF)

    S9 Fig. FtsWE289G is a unique mutant that suppresses the depletion of FtsN.

    (A) Complementation test of the FtsW mutants using strain SD237. (B) Spot test of the ability of FtsW mutants to rescue the growth of FtsN depletion strain at non-permissive condition. The tests were done as in Fig 3.

    (TIF)

    S10 Fig. FtsIK211I is a unique mutant that suppresses the depletion of FtsN.

    (A) Complementation test of the FtsI mutants. Plasmids pDSW208, pLY91 (P204::ftsI) and pLY105 (P204::ftsIK211I) were transformed into strain PS413 (W3110, ftsI23). A single transformant of each resultant strain was resuspended in 1 ml LB and serially diluted by 10. 3 μl of each dilution was spot on LB plates with antibiotics and with or without IPTG. Plates were incubated at 30°C for 24 hours or at 42°C overnight and photographed. (B) Spot test of the ability of FtsI mutants to rescue the growth of FtsN depletion strain at non-permissive condition. Test was done as in S7B Fig.

    (TIF)

    S11 Fig. Overexpression of FtsN and FtsAR286W suppress FtsWA270T but not FtsWM269K.

    (A) spot test of the ability of FtsN overexpression to suppress FtsWA270T and FtsWM269K. (B) Spot test of the ability of FtsAR286W to suppress FtsWA270T and FtsWM269K. The test was carried out as in Fig 9 but in strain SD295 [W3110, ftsW::kan recA56 slrD::Tn10 /pSD257 (pSC101ts, ftsW)] or SD390 [W3110, ftsAR286W, ftsW::kan recA56 slrD::Tn10 /pSD257(pSC101ts, ftsW)]. Note that FtsWA270T was unable to complement the FtsW depletion strain but FtsAR286W suppressed the defect completely. In addition, in the presence of FtsAR286W, less inducer was needed to induce wild type FtsW for complementation.

    (TIF)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES